AKBA vs SHW · rev $102.7M vs P/E 29, rev $12.46B
Akebia Ther (AKBA) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
AKBA currently screens at market cap $260.1M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the AKBA and SHW stock pages for the full models.
Not investment advice.